Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $1.62 Million - $1.89 Million
-5,200 Reduced 40.31%
7,700 $2.76 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $2.94 Million - $4.12 Million
12,900 New
12,900 $4.11 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $20,330 - $24,417
100 Added 8.33%
1,300 $272,000
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $209,772 - $289,368
1,200 New
1,200 $283,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.